Coronavirus Update: The Joint Commission to Suspend Surveying in Response to COVID-19 Outbreak

In response to the novel coronavirus (COVID-19) outbreak, the Joint Commission (TJC) said that beginning today, March 16, it will suspend all TJC surveying. The TJC has notified the Centers for Medicare & Medicaid Services of its decision and CMS has agreed, according to an email sent to stakeholders today.

TJC said that it anticipates that survey delays, as well as other activities, will be on hold at least until the end of April; however, it is conducting planning scenarios that assume longer periods of suspension. TJC said it also is working with its field staff and customers on plans to redirect TJC resources to best assist customers during this constantly changing time.

Related Resources

Case Studies
Riley Children’s Health is working to ensure that children, including those under age 5, get the COVID-19 vaccine, by hosting vaccine clinics across the…
Case Studies
While masks have been removed from most school supply lists this season, health care officials say new variants, such as BA.5, can spread quickly putting kids…
Guides/Reports
Public
At the outset of the COVID-19 pandemic, communities across America entered mandatory quarantines and temporarily shut down many every day services such as…
Case Studies
To encourage Arkansas residents of all ages to get the COVID-19 vaccine and booster, Baptist Health has set up vaccine clinics across the state at banks,…
Advancing Health Podcast
Public
As we start to emerge from the COVID-19 pandemic, understanding and reconnecting to purpose, rediscovering our why is key to moving forward.
Guides/Reports
Member
What is Paxlovid? Paxlovid (ritonavir-boosted nirmatrelvir) is a preferred oral antiviral authorized for the treatment of mild-moderate COVID-19 illness.…